The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Narrative Review: Aspirin Resistance and Its Clinical Implications
Abstract
Aspirin is currently the most cost-effective drug for the secondary prevention of cardiovascular disease, but treatment failures are relatively common. Several factors have been linked to these recurrent vascular events in patients prescribed aspirin, including smoking, drug interactions, nonadherence, comorbid conditions, and aspirin resistance. The term aspirin resistance has been used to describe not only an absence of the expected pharmacologic effects of aspirin on platelets but also poor clinical outcomes, such as recurrent vascular events, in patients treated with aspirin. Aspirin resistance is perhaps more precisely understood as the phenomenon of measurable, persisting platelet activation that occurs in patients prescribed a therapeutic dose of aspirin and may underlie an unknown proportion of aspirin treatment failures. Key challenges for future research are to standardize a definition of aspirin resistance and to compare whether different measures of platelet activation, either alone or in combination, independently predict cardiovascular events. These challenges must be met before researchers conduct studies to assess the clinical utility of testing on patient outcomes and cost-effective prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
Cited by
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Hankey, G. J., & Eikelboom, J. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68040-9 · Cited by 505
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 412
McQuaid, K. R., & Laine, L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.039 · Cited by 409
CUISSET, T., FRERE, C., QUILICI, J., BARBOU, F., MORANGE, P. E., HOVASSE, T., BONNET, J., & ALESSI, M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01751.x · Cited by 369
Metadata
- Authors
- Sanderson, S., Emery, J., Baglin, T., & Kinmonth, A.-L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2005-03-01
- Volume
- 142
- Issue
- 5
- Pages
- 370-380
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2026785948
- Cited by
- 160
- References
- 3
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Narrative Review: Aspirin Resistance and Its Clinical Implications. https://app.cochat.ai/papers/10.7326/0003-4819-142-5-200503010-00012
- The paper
- Sanderson, S., Emery, J., Baglin, T., & Kinmonth, A.-L. (2005). Narrative Review: Aspirin Resistance and Its Clinical Implications. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-142-5-200503010-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.